Mechanistically, HOOK1 inhibited tumor growth and metastasis via canonical and non‐canonical TGF‐β pathway, and inhibited RCC angiogenesis and sunitinib resistance via TNFSF13B/VEGF‐A signaling. Here, TGFB1 is linked to renal cell carcinoma.